RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

ReStore (an exoskeleton for rehabilitation after a stroke)

Product
Developers: ReWalk Robotics
Date of the premiere of the system: September, 2020
Branches: Pharmaceutics, medicine, health care

2020: The announcement of an exoskeleton of ReStore for rehabilitation after a stroke

In the middle of September, 2020 ReWalk Robotics provided new soft ekzokostyum ReStore for rehabilitation of patients after a stroke. Ekzokostyum helps the weakened patient's muscles during the movement and by that facilitates accomplishment of routine tasks. At the same time the soft suit is felt almost like an article of clothing, applies additional force softly and evenly and helps the natural movement of muscles, but does not replace it.

Doctors already tested ekzokostyum ReStore in terms of security and reliability of use at postinsultny patients with weakness of an ankle joint. Weakening of these muscles interferes with normal walking and leads to falling with changes. Besides, people with a hemiplegia try to compensate weakness on the one hand by means of excessive load of joints and muscles of other leg.

The exoskeleton for rehabilitation after a stroke is released

Ekzokostyum ReStore optimizes the movements of an ankle joint, helping the patient at plantar and back bending of an ankle joint during physical therapy. A system consists of a zone belt in which the engines connected to cables are placed, and those, in turn, are connected with "cup" on caviar and "sock" on the patient's foot. Ropes put the dosed pressure upon foot or calves to help the movement of an ankle joint. A system also includes sensors which transfer information to the smartphone. The physiotherapist can use these data for regulation of value of the applied force depending on progress of the patient.

The research showed that ReStore helps patients to improve plantar and back bending of a paretichny anklebone, thereby normalizing gait. It expands possibilities of rehabilitation of millions of people with the violations of mobility caused by an ischemic and hemorrhagic stroke. The device already began to be used in clinical practice in the USA.[1]

Notes